A Study to Evaluate Effects of Proton-pump Inhibitor on Acalabrutinib Capsule When Administered Orally With COCA-COLA in Healthy Participants

NCT04489797 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Infectious Disease

Interventions

DRUG: Acalabrutinib
DRUG: Rabeprazole

Sponsor

AstraZeneca

Collaborators

[object Object]